XML 22 R2.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash and Cash Equivalents $ 3,099,843 $ 1,081,364
Restricted Cash 30,079 30,068
Accounts Receivable, net 1,054,058
Receivable from Fagron 21,173 30,951
Inventories 664,358 1,238,778
Prepaid Expenses and Other Current Assets 750,272 1,884,015
Current Assets of Discontinued Operations 2,981,305 3,952,916
 Total Current Assets 7,547,030 9,272,150
LONG TERM ASSETS    
Fixed Assets, net 1,244,669 1,288,894
Right-of-Use Assets 232,222 317,622
Other Non-Current Assets 52,174 52,174
Total Assets 9,076,095 10,930,840
CURRENT LIABILITIES    
Accounts Payable 9,780,979 7,937,493
Deferred Revenue, current portion 27,779 27,779
Accrued Other Expenses 1,829,554 1,510,053
Product Recall Liability 130,152 305,806
Lease Liabilities 250,361 342,562
Current Liabilities of Discontinued Operations 929,700 1,272,173
Total Current Liabilities 12,948,525 11,395,866
LONG TERM LIABILITIES    
Deferred Revenue, net of current portion 171,302 178,247
Warrant Liabilities, at fair value 5,480,646 7,492
Total Liabilities 18,600,473 11,581,605
MEZZANINE EQUITY    
Convertible Preferred Stock - Par Value $0.0001; 10,000,000 Shares Authorized; Series C Preferred Stock 3,000 Shares Authorized, liquidation preference $110 per share; 3,000 Issued and Outstanding at March 31, 2023 and December 31, 2022 157,303 157,303
STOCKHOLDERS’ DEFICIT    
Common Stock - Par Value $0.0001 ; 200,000,000 Shares Authorized; 167,006,222 and 150,506,222 Issued, 166,483,265 and 149,983,265 Outstanding at March 31, 2023 and December 31, 2022, respectively 15,051 15,051
Additional Paid-in Capital 303,815,511 303,746,217
Accumulated Deficit (313,506,993) (304,564,086)
Treasury Stock - 522,957 Shares, at cost (5,250) (5,250)
Total Stockholders’ Deficit (9,681,681) (808,068)
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit $ 9,076,095 $ 10,930,840